AMILORIDE IN THE TREATMENT OF PRIMARY HYPERALDOSTERONISM AND ESSENTIAL HYPERTENSION
暂无分享,去创建一个
[1] A. Aakvaag,et al. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case. , 1974, The Journal of clinical endocrinology and metabolism.
[2] J. Brown,et al. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess. , 1973, American heart journal.
[3] R. Fraser,et al. A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. , 1973, Clinical science and molecular medicine.
[4] J. Brown,et al. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes. , 1973, Clinical science and molecular medicine. Supplement.
[5] A. Linton,et al. Protective effect of frusemide in acute tubular necrosis and acute renal failure. , 1973, Clinical science.
[6] D. Davies,et al. Amiloride in primary hyperaldosteronism with chronic peptic ulceration. , 1973, British medical journal.
[7] D. Davies,et al. Simultaneous measurement of total exchangeable potassium and sodium using 43 K and 24 Na. , 1973, Metabolism: clinical and experimental.
[8] J. Brown,et al. Comparison of Surgery and Prolonged Spironolactone Therapy in Patients with Hypertension, Aldosterone Excess, and Low Plasma Renin , 1972, British medical journal.
[9] A. Neville,et al. Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin. , 1971, American heart journal.
[10] J. A. Strong,et al. Measurement of total body potassium with a shadow shield whole-body counter: calibration and errors. , 1971, Physics in medicine and biology.
[11] G. Düsterdieck,et al. Estimation of Angiotensin II Concentration in Human Plasma by Radioimmunoassay. Some Applications to Physiological and Clinical States , 1971, European journal of clinical investigation.
[12] I. O'Muircheartaigh,et al. Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. , 1970, Lancet.
[13] G. Wilson,et al. Clinical evaluation of amiloride, a potassium‐sparing diuretic , 1969, Clinical pharmacology and therapeutics.
[14] J. Melby,et al. Aldosteronism in hypertension. The spironolactone response test. , 1968, Annals of internal medicine.
[15] J. Laragh,et al. Amiloride: A Potassium‐Sparing Natriuretic Agent , 1968, Circulation.
[16] J. Brown,et al. Plasma concentration of renin in a patient with Conn's syndrome with fibrinoid lesions of the renal arterioles: the effect of treatment with spironolactone. , 1965, The Journal of endocrinology.
[17] J. Brown,et al. Plasma Renin in a Case of Conn's Syndrome with Fibrinoid Lesions: Use of Spironolactone in Treatment , 1964, British medical journal.
[18] J. Brown,et al. The estimation of renin in human plasma. , 1964, The Biochemical journal.
[19] G. A. Rose,et al. A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS. , 1964, Lancet.
[20] W. Oelkers,et al. Influence of spironolactone on endogenous steroid metabolism in man. , 1976, Clinical science and molecular medicine. Supplement.
[21] J. Robertson,et al. An international collaborative study of renin assay: establishment of the international reference preparation of human renin. , 1975, Clinical science and molecular medicine. Supplement.
[22] K. Boddy. A high sensitivity shadow-shield whole body monitor with scanning-bed and tilting chair geometries, incorporated in a mobile laboratory. , 1967, The British journal of radiology.